Role of mitogen-activated protein kinase in prostaglandin F2α action in human granulosa-luteal cells

Chen Jei Tai, Sung Keun Kang, Kyung Chul Choi, Chii Ruey Tzeng, Peter C K Leung

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

In the ovary it has been demonstrated that PGF activates the phospholipase C (PLC)/diacylglycerol/protein kinase C pathway. However, little is known about the downstream signaling events that mediate subsequent cellular responses such as steroidogenesis. The present study was designed to examine the effect of PGF on activation of the mitogen-activated protein kinase (MAPK) signaling pathway and its physiological role in human granulosa-luteal cells (hGLCs). Human GLCs, obtained from women undergoing in vitro fertilization-embryo transfer, were treated with increasing concentrations of PGF (10 nmol/L to 10 μmol/L) for 5 min. For time-course experiments, hGLCs were treated with 1 μmol/L PGF for 1, 5, 10, or 20 min. Western blot analysis, using a monoclonal antibody that detected the phosphorylated forms of extracellular signal-regulated kinases 1 and 2 (p42mapk and p44mapk, respectively), demonstrated that PGF activated MAPK in hGLCs in a dose- and time-dependent manner. Treatment of the cells with neomycin (10 mmol/L; a PLC inhibitor), bisindolylmaleimide I (5 μmol/L; a PKC inhibitor), or PD98059 (50 μmol/L; a MEK inhibitor and a MAPK kinase inhibitor) significantly attenuated the PGF-induced activation of MAPK. In contrast, MAPK activation was not significantly affected by pertussis toxin (200 ng/mL, a Gi inhibitor) pretreatment. To determine the role of MAPK in steroidogenesis, hGLCs were treated with PGF, (1 μmol/L), hCG (1 IU/mL), or PGF, plus hCG in the presence or absence of PD98059. Progesterone levels in the culture medium were examined by RIA. Treatment of hGLCs with PGF significantly inhibited hCG-induced progesterone production. The presence of the MEK inhibitor, PD98059, reversed the inhibitory effect of PGF on hCG-induced progesterone production. To our knowledge, it is the first demonstration of PGF,-induced activation of the MAPK signaling pathway in the human ovary. These results indicated that PGF activated MAPK subsequent to PLC and PKC activation through pertussis toxin-insensitive G protein in hGLCs. Further, we demonstrated that PGF-induced MAPK activation is associated with modulation of progesterone production. These results support the idea that the MAPK signaling pathway is involved in mediating PGF, actions in the human ovary.

Original languageEnglish
Pages (from-to)375-380
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume86
Issue number1
DOIs
Publication statusPublished - 2001

Fingerprint

Luteal Cells
Dinoprost
Mitogen-Activated Protein Kinases
Chemical activation
Progesterone
Mitogen-Activated Protein Kinase Kinases
Type C Phospholipases
Ovary
Pertussis Toxin
Diacylglycerol Kinase
Neomycin
Mitogen-Activated Protein Kinase 3
Embryo Transfer
Mitogen-Activated Protein Kinase 1
Diglycerides
Fertilization in Vitro
GTP-Binding Proteins
Protein Kinase C

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Role of mitogen-activated protein kinase in prostaglandin F2α action in human granulosa-luteal cells. / Tai, Chen Jei; Kang, Sung Keun; Choi, Kyung Chul; Tzeng, Chii Ruey; Leung, Peter C K.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 86, No. 1, 2001, p. 375-380.

Research output: Contribution to journalArticle

@article{9cd64ee85f4e4bfc8b33ece6bd1bcab5,
title = "Role of mitogen-activated protein kinase in prostaglandin F2α action in human granulosa-luteal cells",
abstract = "In the ovary it has been demonstrated that PGF2α activates the phospholipase C (PLC)/diacylglycerol/protein kinase C pathway. However, little is known about the downstream signaling events that mediate subsequent cellular responses such as steroidogenesis. The present study was designed to examine the effect of PGF2α on activation of the mitogen-activated protein kinase (MAPK) signaling pathway and its physiological role in human granulosa-luteal cells (hGLCs). Human GLCs, obtained from women undergoing in vitro fertilization-embryo transfer, were treated with increasing concentrations of PGF2α (10 nmol/L to 10 μmol/L) for 5 min. For time-course experiments, hGLCs were treated with 1 μmol/L PGF2α for 1, 5, 10, or 20 min. Western blot analysis, using a monoclonal antibody that detected the phosphorylated forms of extracellular signal-regulated kinases 1 and 2 (p42mapk and p44mapk, respectively), demonstrated that PGF2α activated MAPK in hGLCs in a dose- and time-dependent manner. Treatment of the cells with neomycin (10 mmol/L; a PLC inhibitor), bisindolylmaleimide I (5 μmol/L; a PKC inhibitor), or PD98059 (50 μmol/L; a MEK inhibitor and a MAPK kinase inhibitor) significantly attenuated the PGF2α-induced activation of MAPK. In contrast, MAPK activation was not significantly affected by pertussis toxin (200 ng/mL, a Gi inhibitor) pretreatment. To determine the role of MAPK in steroidogenesis, hGLCs were treated with PGF2α, (1 μmol/L), hCG (1 IU/mL), or PGF2α, plus hCG in the presence or absence of PD98059. Progesterone levels in the culture medium were examined by RIA. Treatment of hGLCs with PGF2α significantly inhibited hCG-induced progesterone production. The presence of the MEK inhibitor, PD98059, reversed the inhibitory effect of PGF2α on hCG-induced progesterone production. To our knowledge, it is the first demonstration of PGF2α,-induced activation of the MAPK signaling pathway in the human ovary. These results indicated that PGF2α activated MAPK subsequent to PLC and PKC activation through pertussis toxin-insensitive G protein in hGLCs. Further, we demonstrated that PGF2α-induced MAPK activation is associated with modulation of progesterone production. These results support the idea that the MAPK signaling pathway is involved in mediating PGF2α, actions in the human ovary.",
author = "Tai, {Chen Jei} and Kang, {Sung Keun} and Choi, {Kyung Chul} and Tzeng, {Chii Ruey} and Leung, {Peter C K}",
year = "2001",
doi = "10.1210/jc.86.1.375",
language = "English",
volume = "86",
pages = "375--380",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Role of mitogen-activated protein kinase in prostaglandin F2α action in human granulosa-luteal cells

AU - Tai, Chen Jei

AU - Kang, Sung Keun

AU - Choi, Kyung Chul

AU - Tzeng, Chii Ruey

AU - Leung, Peter C K

PY - 2001

Y1 - 2001

N2 - In the ovary it has been demonstrated that PGF2α activates the phospholipase C (PLC)/diacylglycerol/protein kinase C pathway. However, little is known about the downstream signaling events that mediate subsequent cellular responses such as steroidogenesis. The present study was designed to examine the effect of PGF2α on activation of the mitogen-activated protein kinase (MAPK) signaling pathway and its physiological role in human granulosa-luteal cells (hGLCs). Human GLCs, obtained from women undergoing in vitro fertilization-embryo transfer, were treated with increasing concentrations of PGF2α (10 nmol/L to 10 μmol/L) for 5 min. For time-course experiments, hGLCs were treated with 1 μmol/L PGF2α for 1, 5, 10, or 20 min. Western blot analysis, using a monoclonal antibody that detected the phosphorylated forms of extracellular signal-regulated kinases 1 and 2 (p42mapk and p44mapk, respectively), demonstrated that PGF2α activated MAPK in hGLCs in a dose- and time-dependent manner. Treatment of the cells with neomycin (10 mmol/L; a PLC inhibitor), bisindolylmaleimide I (5 μmol/L; a PKC inhibitor), or PD98059 (50 μmol/L; a MEK inhibitor and a MAPK kinase inhibitor) significantly attenuated the PGF2α-induced activation of MAPK. In contrast, MAPK activation was not significantly affected by pertussis toxin (200 ng/mL, a Gi inhibitor) pretreatment. To determine the role of MAPK in steroidogenesis, hGLCs were treated with PGF2α, (1 μmol/L), hCG (1 IU/mL), or PGF2α, plus hCG in the presence or absence of PD98059. Progesterone levels in the culture medium were examined by RIA. Treatment of hGLCs with PGF2α significantly inhibited hCG-induced progesterone production. The presence of the MEK inhibitor, PD98059, reversed the inhibitory effect of PGF2α on hCG-induced progesterone production. To our knowledge, it is the first demonstration of PGF2α,-induced activation of the MAPK signaling pathway in the human ovary. These results indicated that PGF2α activated MAPK subsequent to PLC and PKC activation through pertussis toxin-insensitive G protein in hGLCs. Further, we demonstrated that PGF2α-induced MAPK activation is associated with modulation of progesterone production. These results support the idea that the MAPK signaling pathway is involved in mediating PGF2α, actions in the human ovary.

AB - In the ovary it has been demonstrated that PGF2α activates the phospholipase C (PLC)/diacylglycerol/protein kinase C pathway. However, little is known about the downstream signaling events that mediate subsequent cellular responses such as steroidogenesis. The present study was designed to examine the effect of PGF2α on activation of the mitogen-activated protein kinase (MAPK) signaling pathway and its physiological role in human granulosa-luteal cells (hGLCs). Human GLCs, obtained from women undergoing in vitro fertilization-embryo transfer, were treated with increasing concentrations of PGF2α (10 nmol/L to 10 μmol/L) for 5 min. For time-course experiments, hGLCs were treated with 1 μmol/L PGF2α for 1, 5, 10, or 20 min. Western blot analysis, using a monoclonal antibody that detected the phosphorylated forms of extracellular signal-regulated kinases 1 and 2 (p42mapk and p44mapk, respectively), demonstrated that PGF2α activated MAPK in hGLCs in a dose- and time-dependent manner. Treatment of the cells with neomycin (10 mmol/L; a PLC inhibitor), bisindolylmaleimide I (5 μmol/L; a PKC inhibitor), or PD98059 (50 μmol/L; a MEK inhibitor and a MAPK kinase inhibitor) significantly attenuated the PGF2α-induced activation of MAPK. In contrast, MAPK activation was not significantly affected by pertussis toxin (200 ng/mL, a Gi inhibitor) pretreatment. To determine the role of MAPK in steroidogenesis, hGLCs were treated with PGF2α, (1 μmol/L), hCG (1 IU/mL), or PGF2α, plus hCG in the presence or absence of PD98059. Progesterone levels in the culture medium were examined by RIA. Treatment of hGLCs with PGF2α significantly inhibited hCG-induced progesterone production. The presence of the MEK inhibitor, PD98059, reversed the inhibitory effect of PGF2α on hCG-induced progesterone production. To our knowledge, it is the first demonstration of PGF2α,-induced activation of the MAPK signaling pathway in the human ovary. These results indicated that PGF2α activated MAPK subsequent to PLC and PKC activation through pertussis toxin-insensitive G protein in hGLCs. Further, we demonstrated that PGF2α-induced MAPK activation is associated with modulation of progesterone production. These results support the idea that the MAPK signaling pathway is involved in mediating PGF2α, actions in the human ovary.

UR - http://www.scopus.com/inward/record.url?scp=0035143307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035143307&partnerID=8YFLogxK

U2 - 10.1210/jc.86.1.375

DO - 10.1210/jc.86.1.375

M3 - Article

C2 - 11232027

AN - SCOPUS:0035143307

VL - 86

SP - 375

EP - 380

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -